|
| 37075704 | Integration of deep learning-based histopathology and transcriptomics reveals key genes associated with fibrogenesis in patients with advanced NASH. | Cell Rep Med | 2023 |
| 37087635 | Dominant-negative variants in CBX1 cause a neurodevelopmental disorder. | Genet Med | 2023 |
| 37340737 | CSF neopterin and quinolinic acid are biomarkers of neuroinflammation and neurotoxicity in FIRES and other infection-triggered encephalopathy syndromes. | Ann Clin Transl Neurol | 2023 |
| 36240780 | En masse organoid phenotyping informs metabolic-associated genetic susceptibility to NASH. | Cell | 2022 |
| 35835205 | Elevated de novo lipogenesis, slow liver triglyceride turnover, and clinical correlations in nonalcoholic steatohepatitis patients. | J Lipid Res | 2022 |
| 35906407 | Dilatation of the bridging cerebral cortical veins in childhood hydrocephalus suggests a malfunction of venous impedance pumping. | Sci Rep | 2022 |
| 32707342 | Inter- and Intra-individual Variation, and Limited Prognostic Utility, of Serum Alkaline Phosphatase in a Trial of Patients With Primary Sclerosing Cholangitis. | Clin Gastroenterol Hepatol | 2021 |
| 33570776 | A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASH. | Hepatology | 2021 |
| 33169409 | Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH. | Hepatology | 2021 |
| 33029936 | Leukoencephalopathy with calcifications and cysts: Genetic and phenotypic spectrum. | Am J Med Genet A | 2021 |
| 32915202 | DNA Methylation and Immune Cell Markers Demonstrate Evidence of Accelerated Aging in Patients with Chronic Hepatitis B Virus or Hepatitis C Virus, with or without Human Immunodeficienct Virus Co-infection. | Clin Infect Dis | 2021 |
| 32559475 | Disease characteristics of MCT8 deficiency: an international, retrospective, multicentre cohort study. | Lancet Diabetes Endocrinol | 2020 |
| 32087795 | Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study. | Lancet Gastroenterol Hepatol | 2020 |
| 31907854 | Spontaneous Fluctuations in Liver Biochemistries in Patients with Compensated NASH Cirrhosis: Implications for Drug Hepatotoxicity Monitoring. | Drug Saf | 2020 |
| 33071176 | PNPLA3 polymorphisms are associated with raised alanine aminotransferase levels in hepatitis C virus genotype 3. | Arab J Gastroenterol | 2020 |
| 32993698 | The incidence of obesity, venous sinus stenosis and cerebral hyperaemia in children referred for MRI to rule out idiopathic intracranial hypertension at a tertiary referral hospital: a 10Â year review. | Fluids Barriers CNS | 2020 |
| 33014081 | Sources and Toxicity of Mercury in the San Francisco Bay Area, Spanning California and Beyond. | J Environ Public Health | 2020 |
| 32923831 | Characterization and Proteome of Circulating Extracellular Vesicles as Potential Biomarkers for NASH. | Hepatol Commun | 2020 |
| 32115759 | Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial. | Hepatology | 2020 |
| 32523627 | Plasma eicosanoids as noninvasive biomarkers of liver fibrosis in patients with nonalcoholic steatohepatitis. | Therap Adv Gastroenterol | 2020 |
| 32384174 | HBV variants are common in the 'immune-tolerant' phase of chronic hepatitis B. | J Viral Hepat | 2020 |
| 32349763 | The incidence of significant venous sinus stenosis and cerebral hyperemia in childhood hydrocephalus: prognostic value with regards to differentiating active from compensated disease. | Fluids Barriers CNS | 2020 |
| 30661255 | The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis. | Hepatology | 2019 |
| 31909352 | Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B. | Hepatol Commun | 2019 |
| 32039401 | Methylation signatures in peripheral blood are associated with marked age acceleration and disease progression in patients with primary sclerosing cholangitis. | JHEP Rep | 2019 |
| 30153359 | Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease. | Hepatology | 2019 |
| 31271665 | Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials. | Hepatology | 2019 |
| 31356634 | Genomic modeling of hepatitis B virus integration frequency in the human genome. | PLoS One | 2019 |
| 31324819 | Large-scale viral genome analysis identifies novel clinical associations between hepatitis B virus and chronically infected patients. | Sci Rep | 2019 |
| 31379058 | Predicting HBsAg clearance in genotype A chronic hepatitis B using HBsAg epitope profiling: A biomarker for functional cure. | Liver Int | 2019 |
| 31306680 | Anti-PD-1 blockade with nivolumab with and without therapeutic vaccination for virally suppressed chronic hepatitis B: A pilot study. | J Hepatol | 2019 |
| 31478832 | Adaptation of hepatitis C virus to interferon lambda polymorphism across multiple viral genotypes. | Elife | 2019 |
| 31274575 | Expansion of phenotype of DDX3X syndrome: six new cases. | Clin Dysmorphol | 2019 |
| 30790229 | Sofosbuvir-velpatasvir single-tablet regimen administered for 12 weeks in a phase 3 study with minimal monitoring in India. | Hepatol Int | 2019 |
| 30993748 | The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials. | Hepatology | 2019 |
| 30930022 | Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis. | Gastroenterology | 2019 |
| 30324553 | Correction to: Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis. | Dig Dis Sci | 2019 |
| 30590481 | Discovery of Half-life of Circulating Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B Infection Using Heavy Water Labeling. | Clin Infect Dis | 2019 |
| 28892558 | The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial. | Hepatology | 2018 |
| 30136045 | Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis. | Dig Dis Sci | 2018 |
| 29859740 | Deferred treatment with sofosbuvir-velpatasvir-voxilaprevir for patients with chronic hepatitis C virus who were previously treated with an NS5A inhibitor: an open-label substudy of POLARIS-1. | Lancet Gastroenterol Hepatol | 2018 |
| 29990488 | Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis. | Gastroenterology | 2018 |
| 29933096 | Improved Bone Safety of Tenofovir Alafenamide Compared to Tenofovir Disoproxil Fumarate Over 2 Years in Patients With Chronic HBV Infection. | Clin Gastroenterol Hepatol | 2018 |
| 29958855 | Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis. | Gastroenterology | 2018 |
| 30144554 | The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options. | J Hepatol | 2018 |
| 29982508 | Identification of a Novel Hepatitis C Virus Genotype From Punjab, India: Expanding Classification of Hepatitis C Virus Into 8 Genotypes. | J Infect Dis | 2018 |
| 29851204 | Safety and efficacy of vesatolimod (GS-9620) in patients with chronic hepatitis B who are not currently on antiviral treatment. | J Viral Hepat | 2018 |
| 30059671 | GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease. | Gastroenterology | 2018 |
| 30413629 | Neurologic phenotypes associated with <i>COL4A1</i>/<i>2</i> mutations: Expanding the spectrum of disease. | Neurology | 2018 |
| 29378197 | TLR7 Agonist Increases Responses of Hepatitis B Virus-Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues. | Gastroenterology | 2018 |